AstraZeneca announces $15bn investment in Chinapublished at 10:09 GMTBreaking
AstraZeneca, which is headquartered in the UK, has just announced it will invest $15bn in China until 2030.
The pharmaceutical company says the investment will be used to expand medicines, manufacturing and research and development.
In a press release from AstraZeneca, Prime Minister Keir Starmer says the company's "expansion and leadership in China will help the British manufacturer continue to grow - supporting thousands of UK jobs".
We'll have more detail on this deal in the next post.
















